Additionally, Axl hasrecently been reported to mediate endocytosis of SARS-CoV-2, whichcauses the current COVID-19 pandemic.85 Results show that blocking the Axl receptor decreases viral infectionin H1299 pulmonary and human primary lung epithelial cells, and proteinlevels in COVID-19 patients correlate with the levels of spike proteinof SARS-CoV-2 in bronchoalveolar fluid cells. The gene discussed is AXL; the disease is COVID-19.